Advisor Group Holdings, Inc. Karyopharm Therapeutics Inc. Transaction History

Advisor Group Holdings, Inc.

  • $44.4 Billion
  • Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,879 shares of KPTI stock, worth $19,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,879
Holding current value
$19,613
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$3.54 - $7.36 $17,271 - $35,909
4,879 New
4,879 $21,000
Q4 2024

Jun 06, 2025
BUY
$0.6 - $0.99 $3,234 - $5,336
5,390 New
5,390 $3,000
Q3 2024

Nov 13, 2024
SELL
$0.7 - $1.06 $1,976 - $2,992
-2,823 Reduced 39.14%
4,390 $3,000
Q2 2024

Aug 13, 2024
SELL
$0.87 - $1.58 $1,202 - $2,183
-1,382 Reduced 16.08%
7,213 $6,000
Q1 2024

May 10, 2024
BUY
$0.72 - $1.66 $1,548 - $3,570
2,151 Added 33.38%
8,595 $12,000
Q4 2023

Feb 12, 2024
SELL
$0.68 - $1.31 $340 - $655
-500 Reduced 7.2%
6,444 $5,000
Q3 2023

Nov 13, 2023
SELL
$1.14 - $1.81 $153 - $244
-135 Reduced 1.91%
6,944 $9,000
Q2 2023

Aug 10, 2023
SELL
$1.79 - $4.59 $3,270 - $8,385
-1,827 Reduced 20.51%
7,079 $12,000
Q4 2022

Feb 10, 2023
BUY
$2.48 - $5.93 $12,660 - $30,272
5,105 Added 134.31%
8,906 $30,000
Q3 2022

Nov 14, 2022
BUY
$4.08 - $5.82 $640 - $913
157 Added 4.31%
3,801 $21,000
Q2 2022

Aug 10, 2022
BUY
$4.15 - $8.37 $8 - $16
2 Added 0.05%
3,644 $16,000
Q1 2022

May 04, 2022
SELL
$5.91 - $14.38 $103,974 - $252,987
-17,593 Reduced 82.85%
3,642 $27,000
Q3 2021

Nov 05, 2021
BUY
$4.45 - $10.63 $37,958 - $90,673
8,530 Added 67.14%
21,235 $124,000
Q2 2021

Aug 02, 2021
SELL
$8.11 - $11.11 $4,428 - $6,066
-546 Reduced 4.12%
12,705 $131,000
Q1 2021

May 13, 2021
SELL
$9.85 - $17.69 $97,692 - $175,449
-9,918 Reduced 42.81%
13,251 $139,000
Q4 2020

Feb 10, 2021
SELL
$14.15 - $17.19 $1,400 - $1,701
-99 Reduced 0.43%
23,169 $359,000
Q3 2020

Nov 12, 2020
SELL
$14.14 - $19.71 $26,866 - $37,449
-1,900 Reduced 7.55%
23,268 $340,000
Q2 2020

Aug 14, 2020
BUY
$16.6 - $25.25 $129,480 - $196,950
7,800 Added 44.91%
25,168 $477,000
Q1 2020

May 18, 2020
BUY
$14.38 - $27.72 $249,751 - $481,440
17,368 New
17,368 $333,000

Others Institutions Holding KPTI

# of Institutions
7
Shares Held
4.39M
Call Options Held
0
Put Options Held
0
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $321M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email